TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2026
Voltar para busca
Dado oficial do USPTO
CONTERA PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
08/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
19/06/2023
Data de registro
05/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/11/2024
Última transação
08/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
24
Localização do titular
DK
Examinador
HUDSON, TAMARA BREE
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "CONTERA PHARMA" in stylized blue font above a series of vertical blue lines positioned to form a horizontal rectangular shape.
Titulares e representantes
Titulares
Contera Pharma A/S
C. A. (pessoa física)
Representantes
Julie A. Greenberg Reising Ethington P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Antibiotics; antiviralschemical preparations for pharmaceutical purposesfor treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; drugs for medical purposespharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; medicines for human purposes for treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; pharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; vitamin preparations; health supplements for medical usehealth food supplementsdietary and nutritional supplementsherbal supplements
Classe 35
Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; analysis of market search data; market research studies; advertising services; arranging of pharmaceutical saleprocuring of contracts for others for the purchase and sale of pharmaceuticals; export-import agency services; sales agency business of health supplementary foodmarketing services for health supplementary foodspromotional marketing and representation services for sales to the public sector of health supplementary foodindependent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2026
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/10/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/09/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/04/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/04/2025
FIMP
FINAL DISPOSITION PROCESSED
08/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/02/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/12/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2024
PUBO
PUBLISHED FOR OPPOSITION
20/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2024
RFNT
REFUSAL PROCESSED BY IB
29/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/03/2024
RFRR
REFUSAL PROCESSED BY MPU
29/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/03/2024
CNRT
NON-FINAL ACTION WRITTEN
07/03/2024
DOCK
ASSIGNED TO EXAMINER
07/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/08/2023
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
21/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CONTERA PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.